Glioblastoma
📧 Sign up to get email alerts when something new happens for Glioblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Evaluation of the Predictive Value of 18F-fluorodeoxyglucose Positron Emission Tomography and Brain Perfusion Computed Tomography for the Efficacy of Anti-angiogenic Therapy (Bevacizumab) in Recurrent Glioblastoma [NA]
This clinical trial update reports on a completed study that evaluated whether 18F-fluorodeoxyglucose PET and brain perfusion CT can predict…
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: FET-PET/MRI Based Treatment Planning for Glioblastoma Multiforme in Post-Surgical Patients (FET-TREAT)
The FET-PET/MRI based treatment planning trial for glioblastoma multiforme in post-surgical patients has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma [Phase 2]
A Phase 2 trial of Paxalisib in glioblastoma, evaluating a high-fat, low-carb diet with metformin, has been suspended.
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Neuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: A Phase 0 Clinical Trial [EARLY_Phase 1]
This document reports the termination of a Phase 0/early Phase 1 trial evaluating repurposed posaconazole for glioblastoma, with results pos…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: FDG PET/CT in Monitoring Very Early Therapy Response in Patients With Glioblastoma [NA]
This update reports that the clinical trial examining FDG PET/CT for monitoring very early therapy response in glioblastoma has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: Identification of Treatment Concentrations of Defactinib or VS-6766 for the Treatment of Patients With Glioblastoma [EARLY_Phase 1]
An early-phase 1 clinical trial at Emory University is identifying treatment concentrations for Defactinib and VS-6766 in patients with glio…
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: Study of Tinostamustine for Adjuvant Treatment of Glioblastoma [EARLY_Phase 1]
Completed EARLY Phase 1 clinical trial investigating tinostamustine as adjuvant treatment for glioblastoma.
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: Safety And Effectiveness Of NaviFUS System With Bevacizumab In Recurrent Glioblastoma [NA]
This clinical trial update describes a study of the NaviFUS System combined with bevacizumab for recurrent glioblastoma, focusing on safety …
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: OKN-007 in Combination With Adjuvant Temozolomide Chemoradiotherapy for Newly Diagnosed Glioblastoma [Phase 1]
An update on a Phase 1 trial evaluating OKN-007 in combination with adjuvant temozolomide chemoradiotherapy for newly diagnosed glioblastoma…
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: Dose Finding for Intraoperative Photodynamic Therapy of Glioblastoma [Phase 2]
Phase 2 dose-finding study evaluating intraoperative photodynamic therapy for glioblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-11-28Clinical Trial Update: First-in-Human, Phase 1b/2a Trial of a Multipeptide Therapeutic Vaccine in Patients With Progressive Glioblastoma [Phase 1, Phase 2]
The document reports completion of a first-in-human Phase 1b/2a trial of a multipeptide therapeutic vaccine for progressive glioblastoma, wi…
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: Multi-kinase Inhibitor TG02 (TG02) in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma. [Phase 1]
Phase 1 trial of the multi-kinase inhibitor TG02 in elderly newly diagnosed or adult relapsed patients with anaplastic astrocytoma or gliobl…
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: Nivolumab in Patients With IDH-Mutant Gliomas With and Without Hypermutator Phenotype [Phase 2]
A Phase 2 trial of nivolumab in IDH-mutant gliomas, with and without hypermutator phenotype, has results posted on ClinicalTrials.gov.
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: A Study in Recurrent Glioblastoma (GB) [Phase 2]
Phase 2 results from a Lilly-sponsored study in recurrent glioblastoma have been posted.
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: Safety and Preliminary Efficacy of a Metabolically Armed Chimeric Antigen Receptor T Cell Therapy Targeting EGFRvIII for Recurrent Glioblastoma [EARLY_Phase 1]
An early-phase trial update reports safety and preliminary efficacy of a metabolically armed CAR-T cell therapy targeting EGFRvIII in recurr…
-
CLINICAL_TRIALS trial_result · 2025-11-19Clinical Trial Update: Phase I Pilot Study to Evaluate the Anti-glioblastoma Effect of S-Gboxin in Standard Treatment of Glioblastoma/Diffuse Midline Glioma and Response to Treatment (Regardless of Mutation Status) [Phase 1]
A Phase I pilot study evaluating S-Gboxin in combination with standard glioblastoma therapy; the trial assessing anti-glioblastoma effects i…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005) [Phase 2]
Phase 2 trial evaluating pembrolizumab plus lenvatinib in previously treated patients with select solid tumors; results on efficacy and safe…
-
CLINICAL_TRIALS trial_result · 2025-11-13Clinical Trial Update: Testing the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain Cancer [Phase 1]
A Phase 1 clinical trial of AMG 232 (KRT-232) in patients with brain cancers including glioblastoma and gliosarcoma was terminated; the stud…
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer [Phase 1, Phase 2]
This document details an ongoing Phase 1/2 clinical trial evaluating cobolimab in combination with dostarlimab in pediatric and young adult …
-
CLINICAL_TRIALS trial_result · 2025-11-10Clinical Trial Update: Neoadjuvant Chemoradiation for Resectable Glioblastoma [Phase 2]
A Phase 2 trial evaluating neoadjuvant chemoradiation for resectable glioblastoma was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-10-24Clinical Trial Update: Infigratinib in Recurrent High-Grade Glioma Patients [EARLY_Phase 1]
Early-phase trial of infigratinib in patients with recurrent high-grade glioma, including glioblastoma, was terminated; results have been po…
-
CLINICAL_TRIALS trial_result · 2025-10-22Clinical Trial Update: ASP8374 + Cemiplimab in Recurrent Glioma [Phase 1]
Phase 1 trial evaluating ASP8374 in combination with cemiplimab for recurrent glioblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-10-21Clinical Trial Update: Solriamfetol in Improving Sleep in Patients With Grade II-IV Glioma [Phase 2]
A Phase 2 trial of solriamfetol for sleep improvement in patients with glioma (grade II–IV) including glioblastoma was terminated, with resu…
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: Assessment of Optune Therapy for Patients With Newly Diagnosed Glioblastoma Using Advanced MRI
Clinical trial update on Optune tumor-treating fields therapy for newly diagnosed glioblastoma, incorporating advanced MRI, with status list…
-
CLINICAL_TRIALS trial_result · 2025-10-14Clinical Trial Update: A Study of TAS2940 in Participants With Locally Advanced or Metastatic Solid Tumor Cancer [Phase 1]
A Phase 1 study evaluating TAS2940 in locally advanced or metastatic solid tumors has been terminated. The trial enrolled patients with glio…